Evidence map›Paper›PMID 40729087›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

The Significant Role of RUNX2 Expression in Women with Metastatic Breast Cancer.

Mitra Rezaei, Neda Mansouri, Zihab Sohbatzadeh, Rezvaneh Ghadyani, Shahrzad Soleimani, Marzieh Motallebi, Ehsan Parsa Zad, Maryam Torkaman, Ali Asghar Kolahi, Abolfazl Movafagh

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mitra RezaeiDepartment of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Neda MansouriInstituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca). IBSAL and CIBERONC, Salamanca, Spain.ORCID 0000-0002-3927-3757
Zihab SohbatzadehDepartment of Physics, University of Sistan and Baluchestan, Zahedan, Iran.ORCID 0000-0003-1938-3614
Rezvaneh GhadyaniDepartment of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Shahrzad SoleimaniDepartment of Molecular Genetics, Institute of Basic Science, Shahrekord Islamic Azad University, Iran.
Marzieh MotallebiDepartment of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ehsan Parsa ZadDepartment of Bioscience and Biotechnology, Malek Ashtar University, Tehran, Iran.ORCID 0000-0001-6224-0606
Maryam TorkamanInstituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca). IBSAL and CIBERONC, Salamanca, Spain.ORCID 0009-0004-7218-0490
Ali Asghar KolahiSocial Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-0178-3732
Abolfazl MovafaghDepartment of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-7402-7677

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveBreast cancer (BC) is one of the most common malignancies with second ranks among the causes of tumor-associated mortality in females. Since the overexpression of RUNX2 gene were reported in the development of different malignancies. The present investigation was aimed to find its correlation with prognostic factors viz, tumor grade and stage in the breast cancer patients.

methodsThis study, examined the expression level changes of RUNX2 genes with the Real-time PCR and compared the results with various databases and previous research results, to understand the existence of differences between metastatic breast cancer patients' samples and non-metastatic BC samples of patients.

resultsThe prepared samples were divided into two target and control groups and different analyses after QPCR reaction were accomplished to understand the level of changes and significance.

conclusionResults of this study suggest that an elevated RUNX2 gene expression level could be a valuable independent predictor of tumor metastasis and survival prediction in invasive breast cancer patients. However, to reach more reliable results and better conclusions more samples, studies, and techniques are needed.

Indexed as

Biomarkers, TumorBreast NeoplasmsCore Binding Factor Alpha 1 SubunitAdultCase-Control StudiesFemaleFollow-Up StudiesGene Expression Regulation, NeoplasticHumansMiddle AgedNeoplasm MetastasisNeoplasm StagingPrognosisSurvival RateBiomarkers, TumorCore Binding Factor Alpha 1 SubunitRUNX2 protein, humanbreast cancerHER2 positiveMetastasisRUNX2 gene

Identifiers

PMID40729087
PMCPMC12530654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.